From a Drug Repositioning to a Structure-Based Drug Design Approach To Tackle Acute Lymphoblastic Leukemia

Scientists presented the development of a potent inhibitor of deoxycytidine kinase by applying an iterative multidisciplinary approach, which relied on computational design coupled with experimental evaluations.